{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:34:47Z","timestamp":1791038087865,"version":"4.1.0"},"reference-count":164,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Food and Chemical Toxicology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.fct.2016.11.001","type":"journal-article","created":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T15:45:44Z","timestamp":1478187944000},"page":"449-471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":154,"special_numbering":"PA","title":["An overview of herb and dietary supplement efficacy, safety and government regulations in the United States with suggested improvements. Part 1 of 5 series"],"prefix":"10.1016","volume":"107","author":[{"given":"Amy Christine","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.fct.2016.11.001_bib2","doi-asserted-by":"crossref","first-page":"966","DOI":"10.2146\/ajhp140574","article-title":"Regulatory alerts for dietary supplements in Canada and the United States, 2005-13","volume":"72","author":"Abe","year":"2015","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.fct.2016.11.001_bib3","series-title":"The AHPA NDI Database","author":"American Herbal Products Association","year":"2015"},{"key":"10.1016\/j.fct.2016.11.001_bib4","series-title":"GNC reaches agreement with New York Attorney General","author":"Anonymous-a","year":"2015"},{"key":"10.1016\/j.fct.2016.11.001_bib5","unstructured":"Anonymous-b. Chapter V \u2013 Drugs and devices. http:\/\/biotech.law.lsu.edu\/blaw\/FDA\/fdcact5a.htm. accessed 11. 01. 16."},{"issue":"1","key":"10.1016\/j.fct.2016.11.001_bib6","first-page":"10","article-title":"DOJ announces supplement sweep \u2013 CRN, NPA, AHPA express support","volume":"21","author":"Anonymous-c","year":"2016","journal-title":"Niemagazine. Com."},{"key":"10.1016\/j.fct.2016.11.001_bib7","series-title":"Office of Inspector General. Adverse Event Reporting for Dietary Supplements. An Inadequate Safety Valve. OEI-01-00-00180","author":"Anonymous-d","year":"2001"},{"key":"10.1016\/j.fct.2016.11.001_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2015.08.001","article-title":"Discovery and resupply of pharmacologically active plant-derived natural products: a review","author":"Atanasov","year":"2015","journal-title":"Biotechnol. Adv."},{"issue":"3","key":"10.1016\/j.fct.2016.11.001_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17030331","article-title":"Scientific and regulatory perspectives in herbal and dietary supplement associated hepatotoxicity in the United States","volume":"17","author":"Avigan","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.fct.2016.11.001_bib10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/jamainternmed.2013.2299","article-title":"Why US adults use dietary supplements","volume":"173","author":"Bailey","year":"2013","journal-title":"JAMA Intern Med."},{"key":"10.1016\/j.fct.2016.11.001_bib11","series-title":"NPA launches warning letter database for member companies","author":"Bartolomeo","year":"2016"},{"issue":"6","key":"10.1016\/j.fct.2016.11.001_bib12","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s11606-008-0632-y","article-title":"Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at University of California, San Francisco Medical Center","volume":"23","author":"Bent","year":"2008","journal-title":"J.\u00a0Gen. Intern Med."},{"issue":"7","key":"10.1016\/j.fct.2016.11.001_bib13","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.amjmed.2003.10.036","article-title":"Commonly used herbal medicines in the United States: a review","volume":"116","author":"Bent","year":"2004","journal-title":"Am. J. Med."},{"key":"10.1016\/j.fct.2016.11.001_bib14","article-title":"Vendor qualification","author":"Blakemore","year":"2015","journal-title":"Nat. Prod. Insid."},{"issue":"9","key":"10.1016\/j.fct.2016.11.001_bib15","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/jama.281.9.824","article-title":"Postmarketing surveillance and adverse drug reactions: current perspectives and future needs","volume":"3;281","author":"Brewer","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.fct.2016.11.001_bib16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.fct.2016.11.001","article-title":"An overview of herb and dietary supplement efficacy, safety, and government regulation in the United States with suggested improvements","volume":"107","author":"Brown","year":"2017","journal-title":"Part 1 of 5 Ser. Food Chem. Toxicol."},{"key":"10.1016\/j.fct.2016.11.001_bib17","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.fct.2016.07.001","article-title":"Liver toxicity related to herb and dietary supplements: online table of medical case reports","volume":"107","author":"Brown","year":"2017","journal-title":"Part 2 of 5 Ser. Food Chem. Toxicol."},{"key":"10.1016\/j.fct.2016.11.001_bib18","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.fct.2016.07.024","article-title":"Kidney toxicity related to herb and dietary supplements: online Table\u00a0of medical case reports","volume":"107","author":"Brown","year":"2017","journal-title":"Part 3 of 5 Ser. Food Chem. Toxicol."},{"key":"10.1016\/j.fct.2016.11.001_bib19","article-title":"Heart toxicity related to herb and dietary supplements: online table of medical case reports","author":"Brown","year":"2017","journal-title":"Part 4 of 5 Ser."},{"key":"10.1016\/j.fct.2016.11.001_bib20","article-title":"Cancer related to herb and dietary supplements: online table of medical case reports","author":"Brown","year":"2017","journal-title":"Part 5 of 5 Ser."},{"issue":"5","key":"10.1016\/j.fct.2016.11.001_bib21","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/15563650701365875","article-title":"Traditional kava beverage consumption and liver function tests in a predominantly Tongan population in Hawaii","volume":"45","author":"Brown","year":"2007","journal-title":"Clin. Toxicol."},{"issue":"1","key":"10.1016\/j.fct.2016.11.001_bib22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tox.2006.01.012","article-title":"The importance of GRAS to the functional food and nutraceutical industries","volume":"221","author":"Burdock","year":"2006","journal-title":"Toxicology"},{"issue":"4","key":"10.1016\/j.fct.2016.11.001_bib23","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11883-015-0495-8","article-title":"Red yeast rice for the treatment of dyslipidemia","volume":"17","author":"Burke","year":"2015","journal-title":"Curr. Atheroscler. Rep."},{"issue":"7","key":"10.1016\/j.fct.2016.11.001_bib163","first-page":"87","article-title":"Dietary supplements: Nutritional and legal considerations","volume":"53","author":"Camire","year":"1999","journal-title":"Food Technol."},{"key":"10.1016\/j.fct.2016.11.001_bib1","unstructured":"CDC (Centers of Disease Control and Prevention), 2016. Prescription opioid overdose data. http:\/\/www.cdc.gov\/drugoverdose\/data\/overdose.html (accessed 04.05.16)."},{"key":"10.1016\/j.fct.2016.11.001_bib24","series-title":"Adverse Events Associated with Ephedrine-containing Products\u2014Texas, December 1993\u2013September 1995","first-page":"689","author":"CDC (Centers of Disease Control and Prevention)","year":"1996"},{"issue":"4","key":"10.1016\/j.fct.2016.11.001_bib25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/15563650600671712","article-title":"Aristolochic acids detected in some raw Chinese medicinal herbs and manufactured herbal products\u2013a consequence of inappropriate nomenclature and imprecise labelling?","volume":"44","author":"Cheung","year":"2006","journal-title":"Clin. Toxicol. (Phila)"},{"key":"10.1016\/j.fct.2016.11.001_bib27","series-title":"A\u00a0supplements legislation timeline. New Hope Network","author":"Clute","year":"2010"},{"key":"10.1016\/j.fct.2016.11.001_bib28","series-title":"Airborne Settles Lawsuit for $23.3 Million","author":"CNN","year":"2008"},{"issue":"9","key":"10.1016\/j.fct.2016.11.001_bib29","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1055\/s-0035-1545843","article-title":"DNA-based authentication of botanicals and plant-derived dietary supplements: where have we been and where are we going?","volume":"81","author":"Coutinho Moraes","year":"2015","journal-title":"Planta Med."},{"issue":"2","key":"10.1016\/j.fct.2016.11.001_bib30","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jada.2010.12.009","article-title":"Is red yeast rice safe and effective for lowering serum cholesterol?","volume":"111","author":"Cunningham","year":"2011","journal-title":"J.\u00a0Am. Diet. Assoc."},{"issue":"1","key":"10.1016\/j.fct.2016.11.001_bib31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.yrtph.2015.06.013","article-title":"Dietary supplements: international legal framework and adulteration profiles, and characteristics of products on the Brazilian clandestine market","volume":"73","author":"da Justa Neves","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"2","key":"10.1016\/j.fct.2016.11.001_bib32","first-page":"48","article-title":"Testing ingredients and components for identity and quality","volume":"21","author":"Danko","year":"2016","journal-title":"Nat. Prod. Insid."},{"issue":"25","key":"10.1016\/j.fct.2016.11.001_bib33","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1056\/NEJMra020398","article-title":"Herbal remedies","volume":"347","author":"De Smet","year":"2002","journal-title":"NEJM"},{"issue":"2","key":"10.1016\/j.fct.2016.11.001_bib34","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/07315724.2013.875423","article-title":"Consumer usage and reasons for using dietary supplements: report of a series of surveys","volume":"33","author":"Dickinson","year":"2014","journal-title":"J.\u00a0Am. Coll. Nutr."},{"issue":"10","key":"10.1016\/j.fct.2016.11.001_bib36","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.jand.2014.04.015","article-title":"A\u00a0free new dietary supplement label database for registered dietitian nutritionists","volume":"114","author":"Dwyer","year":"2014","journal-title":"J.\u00a0Acad. Nutr. Diet."},{"key":"10.1016\/j.fct.2016.11.001_bib37","series-title":"FDA Uses New Authorities to Get OxyElite Pro off the Market","author":"Fabricant","year":"2015"},{"issue":"6","key":"10.1016\/j.fct.2016.11.001_bib38","first-page":"965","article-title":"Medicinal plants in therapy","volume":"63","author":"Farnsworth","year":"1985","journal-title":"Bull. World Health Organ"},{"key":"10.1016\/j.fct.2016.11.001_bib39","article-title":"(U.S. Food and Drug Administration)","volume":"21","author":"FDA-1","year":"2010","journal-title":"CFR - Code Fed. Regul. Title"},{"issue":"9","key":"10.1016\/j.fct.2016.11.001_bib50","first-page":"9","article-title":"FDA Consumer Reports. Are drugs made abroad safe to take?","volume":"26","author":"FDA-2","year":"2014","journal-title":"Consum. Rep. Health"},{"key":"10.1016\/j.fct.2016.11.001_bib61","unstructured":"FDA-3. Dietary supplements. 12\/21\/2015. http:\/\/www.fda.gov\/Food\/DietarySupplements\/. accessed 22. 12. 15."},{"key":"10.1016\/j.fct.2016.11.001_bib64","unstructured":"FDA-4. Dietary Supplement Current Good Manufacturing Practices (CGMPs) and Interim Final Rule (IFR) Facts. http:\/\/www.fda.gov\/Food\/GuidanceRegulation\/CGMP\/ucm110858.htm. accessed 15. 11. 15."},{"key":"10.1016\/j.fct.2016.11.001_bib65","unstructured":"FDA-5. Dietary supplements containing ephedrine alkaloids; proposed rule. Food and Drug Administration. Fed. Reg. 62: 30678\u201330724. http:\/\/www.fda.gov\/ohrms\/dockets\/98fr\/97-14393.htm. accessed 11. 01. 16."},{"key":"10.1016\/j.fct.2016.11.001_bib66","unstructured":"FDA-6. Draft guidance for industry: Dietary supplements: New dietary ingredient notifications and related issues. http:\/\/www.fda.gov\/Food\/GuidanceRegulation\/GuidanceDocumentsRegulatoryInformation\/DietarySupplements\/ucm257563.htm. 15. 11. 15."},{"key":"10.1016\/j.fct.2016.11.001_bib67","unstructured":"FDA-7. Drugs@FDA glossary of terms. http:\/\/www.fda.gov\/Drugs\/InformationOnDrugs\/ucm079436.htm. accessed 12. 12. 15."},{"key":"10.1016\/j.fct.2016.11.001_bib68","series-title":"Energy \u201cdrinks\u201d and Supplements: Investigators of Adverse Events Reports","author":"FDA-8","year":"2012"},{"key":"10.1016\/j.fct.2016.11.001_bib69","unstructured":"FDA-9. FDA creates the Office of Dietary Supplement Programs and announces new nutrition office leadership. 12\/21\/15. http:\/\/www.fda.gov\/Food\/NewsEvents\/ConstituentUpdates\/ucm478303.htm. accessed 22. 12. 15."},{"key":"10.1016\/j.fct.2016.11.001_bib40","unstructured":"FDA-10. FDA industry systems. New dietary ingredient notification step-by-step instructions. accessed 15. 12. 15."},{"key":"10.1016\/j.fct.2016.11.001_bib41","unstructured":"FDA-11. Generally recognized as safe (GRAS). http:\/\/www.fda.gov\/Food\/IngredientsPackagingLabeling\/GRAS\/default.htm. accessed 15. 11. 15."},{"key":"10.1016\/j.fct.2016.11.001_bib42","article-title":"Guidance for industry","author":"FDA-12","year":"2004","journal-title":"Bot. Drug Prod."},{"key":"10.1016\/j.fct.2016.11.001_bib43","unstructured":"FDA-13. Guidance for industry: Evidence-based review system for the scientific evaluations of health claims. http:\/\/www.fda.gov\/Food\/GuidanceRegulation\/GuidanceDocumentsRegulatoryInformation\/ucm073332.htm. accessed 15. 11. 15."},{"key":"10.1016\/j.fct.2016.11.001_bib44","unstructured":"FDA-14. Guidance for industry: What you need to know about administrative detention of foods; small entity compliance guide. http:\/\/www.fda.gov\/Food\/GuidanceRegulation\/GuidanceDocumentsRegulatoryInformation\/FoodDefense\/ucm342588.htm. accessed 21. 7. 16."},{"key":"10.1016\/j.fct.2016.11.001_bib45","unstructured":"FDA-15. Hydroxycut Products. 6\/18\/2009. www.fda.gov\/NewsEvents\/PublicHealthFocus\/ucm155683.htm. accessed 11. 01. 16."},{"key":"10.1016\/j.fct.2016.11.001_bib46","unstructured":"FDA-16. Implementation of the Dietary Supplement Health and Education Act (DSHEA) of 1994. http:\/\/www.fda.gov\/NewsEvents\/Testimony\/ucm115082.htm. 3\/29\/1999. accessed 21. 12. 15."},{"key":"10.1016\/j.fct.2016.11.001_bib47","unstructured":"FDA-17. Label claims for conventional foods and dietary supplements. http:\/\/www.fda.gov\/Food\/IngredientsPackagingLabeling\/LabelingNutrition\/ucm111447.htm. accessed 21. 12. 15."},{"key":"10.1016\/j.fct.2016.11.001_bib48","unstructured":"FDA-18. Medication health fraud. http:\/\/www.fda.gov\/Drugs\/ResourcesForYou\/Consumers\/BuyingUsingMedicineSafely\/MedicationHealthFraud\/default.htm. accessed 13. 03. 16."},{"key":"10.1016\/j.fct.2016.11.001_bib49","unstructured":"FDA-19. New dietary ingredients in dietary supplements \u2013 background for industry. http:\/\/www.fda.gov\/Food\/DietarySupplements\/ucm109764.htm. accessed 11. 01. 16."},{"key":"10.1016\/j.fct.2016.11.001_bib51","unstructured":"FDA-20. New drug application (NDA). http:\/\/www.fda.gov\/Drugs\/DevelopmentApprovalProcess\/HowDrugsareDevelopedandApproved\/ApprovalApplications\/NewDrugApplicationNDA\/. accessed 15. 11. 15."},{"key":"10.1016\/j.fct.2016.11.001_bib52","unstructured":"FDA-21. OxyElite Pro Supplements Recalled. http:\/\/www.fda.gov\/forconsumers\/consumerupdates\/ucm374742.htm. Accessed 15. 11. 15."},{"key":"10.1016\/j.fct.2016.11.001_bib53","unstructured":"FDA-22. Premarket notification for a new dietary ingredient, final rule. Food and Drug Administration. Fed. http:\/\/www.fda.gov\/ohrms\/dockets\/dockets\/95s0316\/95s-0316-rpt0299-052-Appendix-A-Tab-F-Ref-046-FDA-1997A-vol2.pdf. accessed 11. 01. 16."},{"key":"10.1016\/j.fct.2016.11.001_bib54","unstructured":"FDA-23. Reports received and reports entered into FAERS by year. http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Surveillance\/AdverseDrugEffects\/ucm070434.htm. accessed 15. 07. 16."},{"key":"10.1016\/j.fct.2016.11.001_bib55","article-title":"Statement by Jane E. Henney, M.D., commissioner food and drug administration, department of health and human services, before the committee on government reform","author":"FDA-24","year":"1999","journal-title":"U.S. House Represent."},{"key":"10.1016\/j.fct.2016.11.001_bib56","unstructured":"FDA-25. Stimulant potentially dangerous to health, FDA warns. http:\/\/www.fda.gov\/ForConsumers\/ConsumerUpdates\/ucm347270.htm. accessed 16. 05. 16."},{"key":"10.1016\/j.fct.2016.11.001_bib57","unstructured":"FDA-26. Structure\/Function claims. http:\/\/www.fda.gov\/Food\/IngredientsPackagingLabeling\/LabelingNutrition\/ucm2006881.htm. accessed 15. 1. 16."},{"key":"10.1016\/j.fct.2016.11.001_bib58","unstructured":"FDA-27. Summary of qualified health claims subject to enforcement discretion. http:\/\/www.fda.gov\/Food\/IngredientsPackagingLabeling\/LabelingNutrition\/ucm073992.htm. accessed 15. 1. 16."},{"key":"10.1016\/j.fct.2016.11.001_bib59","unstructured":"FDA-28. Use caution with Ayurvedic producs. http:\/\/www.fda.gov\/ForConsumers\/ConsumerUpdates\/ucm050798.htm. accessed 21. 10. 16."},{"key":"10.1016\/j.fct.2016.11.001_bib60","unstructured":"FDA-29. USPlabs LLC recalls OxyElite Pro dietary supplements; products linked to liver illnesses. http:\/\/www.fda.gov\/newsevents\/newsroom\/pressannouncements\/ucm374395.htm. accessed 15. 11. 15."},{"key":"10.1016\/j.fct.2016.11.001_bib62","unstructured":"FDA-30. Warning on Hydroxycut products. http:\/\/www.fda.gov\/ForConsumers\/ConsumerUpdates\/ucm152152.htm. accessed 16. 03. 16."},{"key":"10.1016\/j.fct.2016.11.001_bib63","unstructured":"FDA-31. What is a serious adverse event? http:\/\/www.fda.gov\/Safety\/MedWatch\/HowToReport\/ucm053087.htm. accessed 11. 15. 15."},{"issue":"2","key":"10.1016\/j.fct.2016.11.001_bib70","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep.23696","article-title":"Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop","volume":"52","author":"Fontana","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.fct.2016.11.001_bib71","series-title":"Feds Announce \u2018Sweeping\u2019 Actions Against Supplement Makers","author":"Fox","year":"2015"},{"issue":"2","key":"10.1016\/j.fct.2016.11.001_bib72","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.2009.263","article-title":"FDA regulation of dietary supplements and requirements regarding adverse event reporting","volume":"87","author":"Frankos","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.fct.2016.11.001_bib35","unstructured":"FTC-a. Dietary supplements: An advertising guide for industry. https:\/\/www.ftc.gov\/tips-advice\/business-center\/guidance\/dietary-supplements-advertising-guide-industry#b. accessed 15. 11. 15."},{"key":"10.1016\/j.fct.2016.11.001_bib73","unstructured":"FTC-b. FTC Charges Marketers with Misleading Claims That Their Supplement Causes Weight Loss, Fat Loss, and Increased Metabolism in Women Over Forty. https:\/\/www.ftc.gov\/news-events\/press-releases\/2015\/05\/ftc-charges-marketers-misleading-claims-their-supplement-causes. accessed 15. 11. 15."},{"key":"10.1016\/j.fct.2016.11.001_bib74","unstructured":"FTC-c. Health claims. Health and fitness claims. https:\/\/www.ftc.gov\/news-events\/media-resources\/truth-advertising\/health-claims. accessed 15. 11. 15."},{"issue":"4","key":"10.1016\/j.fct.2016.11.001_bib75","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3945\/jn.113.189803","article-title":"Dietary supplement research portfolio at the NIH, 2009-2011","volume":"144","author":"Garcia-Cazarin","year":"2014","journal-title":"J.\u00a0Nutr."},{"issue":"10","key":"10.1016\/j.fct.2016.11.001_bib76","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/pds.1627","article-title":"The state of dietary supplement adverse event reporting in the United States","volume":"17","author":"Gardiner","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"16","key":"10.1016\/j.fct.2016.11.001_bib77","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1056\/NEJMsa1504267","article-title":"Emergency department visits for adverse events related to dietary supplements","volume":"373","author":"Geller","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.fct.2016.11.001_bib78","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev.publhealth.012809.103649","article-title":"Post-approval drug safety surveillance","volume":"31","author":"Gibbons","year":"2010","journal-title":"Annu. Rev. Public Health"},{"key":"10.1016\/j.fct.2016.11.001_bib79","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jpba.2014.10.011","article-title":"Malet-Martino M.Detection, identification and quantification by 1H NMR of adulterants in 150 herbal dietary supplements marketed for improving sexual performance","volume":"102","author":"Gilard","year":"2015","journal-title":"J.\u00a0Pharm. Biomed. Anal."},{"issue":"Pt B","key":"10.1016\/j.fct.2016.11.001_bib80","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.yebeh.2015.03.004","article-title":"Quality assessment of medicinal herbs and their extracts: criteria and prerequisites for consistent safety and efficacy of herbal medicines","volume":"52","author":"Govindaraghavan","year":"2015","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.fct.2016.11.001_bib81","series-title":"Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements; Final Rule","author":"GPO","year":"2007"},{"issue":"7","key":"10.1016\/j.fct.2016.11.001_bib82","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2146\/ajhp050270","article-title":"Metal content of ephedra-containing dietary supplements and select botanicals","volume":"63","author":"Grippo","year":"2006","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"2","key":"10.1016\/j.fct.2016.11.001_bib83","first-page":"84","article-title":"Dietary supplement adverse events: report of a one-year poison center surveillance project","volume":"4","author":"Haller","year":"2008","journal-title":"JMT"},{"issue":"10","key":"10.1016\/j.fct.2016.11.001_bib84","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1001\/jamainternmed.2013.379","article-title":"The frequency and characteristics of dietary supplement recalls in the United States","volume":"173","author":"Harel","year":"2013","journal-title":"JAMA Intern Med."},{"issue":"1","key":"10.1016\/j.fct.2016.11.001_bib85","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.jsm.0000194766.35443.9c","article-title":"The use of dietary supplements and medications by Canadian athletes at the Atlanta and Sydney Olympic Games","volume":"16","author":"Huang","year":"2006","journal-title":"Clin. J. Sport Med."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.fct.2016.11.001_bib86","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2165\/00002018-199000051-00020","article-title":"The harmful potential of herbal and other plant products","volume":"5","author":"Huxtable","year":"1990","journal-title":"Drug Saf."},{"key":"10.1016\/j.fct.2016.11.001_bib87","series-title":"NBJ Supplement Business Report: a Tough Year for Supplements by the Numbers","author":"Johnson","year":"2015"},{"issue":"3\u20134","key":"10.1016\/j.fct.2016.11.001_bib88","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/dta.1894","article-title":"Hepatotoxicity associated with the dietary supplement OxyELITE Pro\u2122 - Hawaii, 2013","volume":"8","author":"Johnston","year":"2016","journal-title":"Drug Test. Anal."},{"issue":"1","key":"10.1016\/j.fct.2016.11.001_bib89","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jep.2012.12.027","article-title":"Evidence-based toxicity evaluation and scheduling of Chinese herbal medicines","volume":"146","author":"Kim","year":"2013","journal-title":"J.\u00a0Ethnopharmacol."},{"issue":"5","key":"10.1016\/j.fct.2016.11.001_bib164","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1177\/003335491513000515","article-title":"The role of adverse event reporting in the FDA response to a multistate outbreak of liver disease associated with a dietary supplement","volume":"130","author":"Klontz","year":"2015","journal-title":"Public Health Rep."},{"issue":"6","key":"10.1016\/j.fct.2016.11.001_bib90","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/0897190014546117","article-title":"Drug-induced hepatotoxicity of select herbal therapies","volume":"27","author":"Korth","year":"2014","journal-title":"J.\u00a0Pharm. Pract."},{"key":"10.1016\/j.fct.2016.11.001_bib91","first-page":"18","article-title":"Exceptions to the new dietary ingredient notification requirement: utilizing GRAS as a path forward","volume":"1","author":"Kruger","year":"2012","journal-title":"Food Technol."},{"issue":"9","key":"10.1016\/j.fct.2016.11.001_bib92","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1745-7599.2003.tb00415.x","article-title":"The regulation of dietary supplements","volume":"15","author":"Larsen","year":"2003","journal-title":"J.\u00a0Am. Acad. Nurse Pract."},{"issue":"15","key":"10.1016\/j.fct.2016.11.001_bib93","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","article-title":"Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies","volume":"279","author":"Lazarou","year":"1998","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.fct.2016.11.001_bib94","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11739-012-0777-x","article-title":"Herbal hepatotoxicity: a hidden epidemic","volume":"8","author":"Licata","year":"2013","journal-title":"Intern Emerg. Med."},{"issue":"10","key":"10.1016\/j.fct.2016.11.001_bib95","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1055\/s-0029-1185468","article-title":"Qianliguang (Senecio scandens) safety dilemma: dose is the key?","volume":"75","author":"Lin","year":"2009","journal-title":"Planta Med."},{"key":"10.1016\/j.fct.2016.11.001_bib96","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/009286150804200501","article-title":"VigiBase, the WHO Global ICSR database system: basic facts","volume":"42","author":"Lindquist","year":"2008","journal-title":"Drug Inf. J."},{"key":"10.1016\/j.fct.2016.11.001_bib98","series-title":"Traditional Herbal Medicine Research Methods: Identification, Analysis, Bioassay, and Pharmaceutical and Clinical Sciences","article-title":"Understanding Traditional Chinese Medicine and Chinese Herbs","author":"Liu","year":"2011"},{"issue":"7","key":"10.1016\/j.fct.2016.11.001_bib99","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1056\/NEJMc1514454","article-title":"Emergency department visits related to dietary supplements","volume":"374","author":"MacKay","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"4 Pt 1","key":"10.1016\/j.fct.2016.11.001_bib100","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/gme.0b013e31816054bf","article-title":"United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity","volume":"15","author":"Mahady","year":"2008","journal-title":"Menopause"},{"key":"10.1016\/j.fct.2016.11.001_bib101","series-title":"Who\u2019s smiling now? Enzyte scammer gets 25 years in prison","author":"Marco","year":"2008"},{"key":"10.1016\/j.fct.2016.11.001_bib165","series-title":"The revision of herbs of commerce","author":"McGuffin","year":"2001"},{"issue":"5","key":"10.1016\/j.fct.2016.11.001_bib102","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.legalmed.2007.04.001","article-title":"A\u00a0study of western pharmaceuticals contained within samples of Chinese herbal\/patent medicines collected from New York City's Chinatown","volume":"9","author":"Miller","year":"2007","journal-title":"Leg. Med."},{"issue":"3","key":"10.1016\/j.fct.2016.11.001_bib103","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.yrtph.2012.01.006","article-title":"Under the law, FDA must grant different standards for new dietary ingredients and food additives","volume":"62","author":"Mister","year":"2012","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"11","key":"10.1016\/j.fct.2016.11.001_bib104","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1001\/jama.290.11.1505","article-title":"Internet marketing of herbal products","volume":"290","author":"Morris","year":"2003","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.fct.2016.11.001_bib105","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3109\/15563650.2014.987397","article-title":"2013 annual report of the American association of poison control centers' national poison data system (NPDS): 31st annual report","volume":"52","author":"Mowry","year":"2014","journal-title":"Clin. Toxicol. (Phila)"},{"issue":"17","key":"10.1016\/j.fct.2016.11.001_bib106","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1001\/jama.2009.585","article-title":"Movement away from phenolphthalein in laxatives","volume":"301","author":"Murphy","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.fct.2016.11.001_bib107","series-title":"DrugFacts: Drug-related hospital emergency room visits","author":"National Institute on Drug Abuse","year":"2015"},{"key":"10.1016\/j.fct.2016.11.001_bib108","series-title":"Report of the commission on dietary supplement labels","author":"Nesheim","year":"1997"},{"issue":"3","key":"10.1016\/j.fct.2016.11.001_bib109","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1021\/np200906s","article-title":"Natural products as sources of new drugs over the 30 years from 1981 to 2010","volume":"75","author":"Newman","year":"2012","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.fct.2016.11.001_bib110","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/1741-7015-11-222","article-title":"DNA barcoding detects contamination and substitution in North American herbal products","volume":"11","author":"Newmaster","year":"2013","journal-title":"BMC Med."},{"key":"10.1016\/j.fct.2016.11.001_bib26","unstructured":"NIH-a. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/results?term=herbs&Search=Search. accessed 07. 07. 16."},{"key":"10.1016\/j.fct.2016.11.001_bib111","unstructured":"NIH-b. National Center for Complementary and Integrative Health. Ephedra. https:\/\/nccih.nih.gov\/health\/ephedra. accessed 16. 01. 16."},{"key":"10.1016\/j.fct.2016.11.001_bib112","unstructured":"NIH-c. National Center for Complementary and Integrative Health. Grants and funding. https:\/\/nccih.nih.gov\/grants. accessed 25. 01. 16."},{"key":"10.1016\/j.fct.2016.11.001_bib113","unstructured":"NIH-d. National Center for Complementary and Integrative Health. Herbs at a glance. https:\/\/nccih.nih.gov\/health\/herbsataglance.htm. accessed 15. 11. 15."},{"key":"10.1016\/j.fct.2016.11.001_bib114","unstructured":"NIH-e. National Institute of Drug Abuse. Anabolic steroid abuse. What are steroidal supplements?. http:\/\/www.drugabuse.gov\/publications\/research-reports\/anabolic-steroid-abuse\/what-are-steroidal-supplements. accessed 17. 11. 15."},{"key":"10.1016\/j.fct.2016.11.001_bib115","unstructured":"NIH-f. Office of Dietary Supplements. Evidence-based review program. https:\/\/ods.od.nih.gov\/Research\/Evidence-Based_Review_Program.aspx. accessed 19. 11. 15."},{"key":"10.1016\/j.fct.2016.11.001_bib116","unstructured":"NIH-g. Office of Dietary Supplements. NIH Centers for advancing research on botanical and other natural products (carbon) program. https:\/\/ods.od.nih.gov\/Research\/Dietary_Supplement_Research_Centers.aspx. accessed 15. 07 16."},{"issue":"1","key":"10.1016\/j.fct.2016.11.001_bib117","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.tox.2006.01.010","article-title":"Marketing dietary supplements in the United States: a review of the requirements for new dietary ingredients","volume":"221","author":"Noonan","year":"2006","journal-title":"Toxicology"},{"key":"10.1016\/j.fct.2016.11.001_bib118","series-title":"Economically Motivated Adulteration in the Dietary Supplement Market Place","author":"Obermeyer","year":"2015"},{"key":"10.1016\/j.fct.2016.11.001_bib119","unstructured":"Office of Dietary Supplements. National Institutes of Health. Dietary Supplement Health and Education Act of 1994. Public Law 103-417. 103rd Congress. https:\/\/ods.od.nih.gov\/About\/DSHEA_Wording.aspx. accessed 15. 11. 15."},{"key":"10.1016\/j.fct.2016.11.001_bib120","series-title":"General Nutrition Center","author":"Oregon","year":"2015"},{"key":"10.1016\/j.fct.2016.11.001_bib121","series-title":"New York Attorney General Targets Supplements at Major Retailers","author":"O'Connor","year":"2015"},{"key":"10.1016\/j.fct.2016.11.001_bib122","series-title":"Eric Schneiderman leads state attorneys general in push for 'comprehensive inquiry' into herbal supplement industry","author":"O'Keeffe","year":"2015"},{"issue":"11","key":"10.1016\/j.fct.2016.11.001_bib123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/0973-7847.95849","article-title":"Historical review of medicinal plants' usage","volume":"6","author":"Petrovska","year":"2012","journal-title":"Pharmacogn. Rev."},{"issue":"3","key":"10.1016\/j.fct.2016.11.001_bib124","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00228-012-1353-z","article-title":"Contamination and adulteration of herbal medicinal products (HMPs): an overview of systematic reviews","volume":"69","author":"Posadzki","year":"2013","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.fct.2016.11.001_bib125","series-title":"A\u00a0Timeline of Regulation in the Dietary Supplement Industry: 1994-2011","author":"Powers","year":"2011"},{"key":"10.1016\/j.fct.2016.11.001_bib126","series-title":"Medmarx adverse drug event reporting","author":"Quantros","year":"2016"},{"issue":"5","key":"10.1016\/j.fct.2016.11.001_bib127","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0041-0101(00)00154-9","article-title":"Plants as source of drugs","volume":"39","author":"Rates","year":"2001","journal-title":"Toxicon"},{"key":"10.1016\/j.fct.2016.11.001_bib128","series-title":"Understanding Normal and Clinical Nutrition","author":"Rolfes","year":"2014"},{"issue":"5","key":"10.1016\/j.fct.2016.11.001_bib129","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/NT.0000000000000122","article-title":"Risky business. Dietary supplement use by athletes","volume":"50","author":"Rosenbloom","year":"2015","journal-title":"Nutr. Today"},{"issue":"8","key":"10.1016\/j.fct.2016.11.001_bib130","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/ajg.2014.159","article-title":"Outbreak of severe hepatitis linked to weight-loss supplement OxyELITE Pro","volume":"109","author":"Roytman","year":"2014","journal-title":"Am. J. Gastroenterol."},{"issue":"23","key":"10.1016\/j.fct.2016.11.001_bib131","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1001\/jama.292.23.2868","article-title":"Heavy metal content of Ayurvedic herbal medicine products","volume":"292","author":"Saper","year":"2004","journal-title":"JAMA"},{"issue":"3\u20134","key":"10.1016\/j.fct.2016.11.001_bib132","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/dta.1940","article-title":"Dietary supplements quality analysis tools from the United States Pharmacopeia","volume":"8","author":"Sarma","year":"2016","journal-title":"Drug Test. Anal."},{"issue":"3","key":"10.1016\/j.fct.2016.11.001_bib133","first-page":"464","article-title":"The development of USP botanical dietary supplement monographs, 1995-2005","volume":"69","author":"Schiff","year":"2006","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.fct.2016.11.001_bib134","series-title":"Industry's Take on Schneiderman's Latest Move: Damn the Facts, Full Speed Ahead","author":"Schultz","year":"2015"},{"key":"10.1016\/j.fct.2016.11.001_bib135","series-title":"Selling Prescription Drugs Illegally","author":"Seeliger","year":"2016"},{"issue":"4","key":"10.1016\/j.fct.2016.11.001_bib136","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00414-014-1120-z","article-title":"Assessing product adulteration in natural health products for laxative yielding plants, Cassia, Senna, and Chamaecrista, in Southern India using DNA barcoding","volume":"129","author":"Seethapathy","year":"2015","journal-title":"Int. J. Leg. Med."},{"issue":"5","key":"10.1016\/j.fct.2016.11.001_bib137","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1024\/0300-9831\/a000124","article-title":"The discovery of the vitamins","volume":"82","author":"Semba","year":"2012","journal-title":"Int. J. Vitam. Nutr. Res."},{"issue":"2","key":"10.1016\/j.fct.2016.11.001_bib138","first-page":"89","article-title":"The demise of ephedra","volume":"21","author":"Shapiro","year":"2016","journal-title":"Nat. Prod. Insid."},{"issue":"17","key":"10.1016\/j.fct.2016.11.001_bib139","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1055\/s-0030-1250533","article-title":"Toxicological risks of Chinese herbs","volume":"76","author":"Shaw","year":"2010","journal-title":"Planta Med."},{"issue":"5","key":"10.1016\/j.fct.2016.11.001_bib140","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2165\/00002018-199717050-00006","article-title":"Traditional remedies and food supplements. A 5-year toxicological study (1991-1995)","volume":"17","author":"Shaw","year":"1997","journal-title":"Drug Saf."},{"issue":"3","key":"10.1016\/j.fct.2016.11.001_bib141","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jep.2012.01.051","article-title":"Pharmacovigilance of herbal medicine","volume":"140","author":"Shaw","year":"2012","journal-title":"J.\u00a0Ethnopharmacol."},{"issue":"11","key":"10.1016\/j.fct.2016.11.001_bib142","first-page":"2764","article-title":"Food and Drug Administration monitoring of adverse drug reactions","volume":"43","author":"Sills","year":"1986","journal-title":"Am. J. Hosp. Pharm."},{"key":"10.1016\/j.fct.2016.11.001_bib143","article-title":"The regulated dietary supplement industry: myths of an unregulated industry dispelled","author":"Soller","year":"2012","journal-title":"HerbalGram"},{"key":"10.1016\/j.fct.2016.11.001_bib144","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.foodchem.2014.09.106","article-title":"Introducing food fraud including translation and interpretation to Russian, Korean, and Chinese languages","volume":"189","author":"Spink","year":"2015","journal-title":"Food Chem."},{"key":"10.1016\/j.fct.2016.11.001_bib145","article-title":"Should states and local governments regulate dietary supplements?","author":"Starr","year":"2015","journal-title":"Drug Test. Anal."},{"issue":"2","key":"10.1016\/j.fct.2016.11.001_bib146","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/gme.0b013e3181c5159c","article-title":"Black cohosh and suspected hepatotoxicity: inconsistencies, confounding variables, and prospective use of a diagnostic causality algorithm","volume":"17","author":"Teschke","year":"2010","journal-title":"A\u00a0Crit. Rev. Menopause"},{"key":"10.1016\/j.fct.2016.11.001_bib147","doi-asserted-by":"crossref","DOI":"10.3390\/medicines3030018","article-title":"Traditional Chinese medicine (TCM) and herbal hepatotoxicity: RUCAM and the role of novel diagnostic biomarkers such as microRNAs","volume":"3","author":"Teschke","year":"2016","journal-title":"Medicines"},{"issue":"1","key":"10.1016\/j.fct.2016.11.001_bib148","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5604\/16652681.1184237","article-title":"The mystery of the Hawaii liver disease cluster in summer 2013: a pragmatic and clinical approach to solve the problem","volume":"15","author":"Teschke","year":"2016","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.fct.2016.11.001_bib149","unstructured":"USDA-a. DRI Tables\u00a0and Application Reports. Dietary Reference Intakes: Recommended Intakes for Individuals. http:\/\/www.nal.usda.gov\/fnic\/DRI\/DRI_Tables\/estimated_average_requirements.pdf. accessed 15. 11. 15."},{"key":"10.1016\/j.fct.2016.11.001_bib150","unstructured":"USDA-b. DRI Tables\u00a0and Application Reports. Dietary Reference Intakes: Tolerable Upper Intake Level Values for Vitamins and Elements. http:\/\/www.nal.usda.gov\/fnic\/DRI\/DRI_Tables\/UL_vitamins_elements.pdf. accessed 15. 11. 15."},{"key":"10.1016\/j.fct.2016.11.001_bib151","article-title":"Admission criteria and safety classification for dietary supplements guideline","volume":"1.1","author":"USP-a","year":"2012","journal-title":"Version"},{"key":"10.1016\/j.fct.2016.11.001_bib152","series-title":"USP Dietary Supplements Compendium","author":"USP-b","year":"2015"},{"key":"10.1016\/j.fct.2016.11.001_bib153","article-title":"USP verified mark","volume":"48","author":"USP-c","year":"2016","journal-title":"Nutr. Ind. Exec."},{"issue":"4","key":"10.1016\/j.fct.2016.11.001_bib154","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4103\/2231-4040.104709","article-title":"Natural products derived from plants as a source of drugs","volume":"3","author":"Veeresham","year":"2012","journal-title":"J.\u00a0Adv. Pharm. Technol. Res."},{"issue":"29","key":"10.1016\/j.fct.2016.11.001_bib155","doi-asserted-by":"crossref","first-page":"6633","DOI":"10.1021\/acs.jafc.5b02105","article-title":"Mycotoxins in plant-based dietary supplements: hidden health risk for consumers","volume":"63","author":"Veprikova","year":"2015","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.fct.2016.11.001_bib156","series-title":"Dietary Supplements in Health Promotion","article-title":"Dietary Supplements in Active Individuals and Athletes","author":"Wallace","year":"2015"},{"issue":"20","key":"10.1016\/j.fct.2016.11.001_bib157","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1001\/archinte.158.20.2192","article-title":"Herbs as medicines","volume":"158","author":"Winslow","year":"1998","journal-title":"Arch. Intern Med."},{"issue":"5","key":"10.1016\/j.fct.2016.11.001_bib158","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/109158180302200509","article-title":"The Dietary Supplement and Health Education Act and supplements: dietary and nutritional supplements need no more regulations","volume":"22","author":"Wollschlaeger","year":"2003","journal-title":"Int. J. Toxicol."},{"issue":"1","key":"10.1016\/j.fct.2016.11.001_bib159","doi-asserted-by":"crossref","first-page":"323S","DOI":"10.1093\/ajcn\/85.1.323S","article-title":"Adverse event monitoring and multivitamin-multimineral dietary supplements","volume":"85","author":"Woo","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.fct.2016.11.001_bib160","series-title":"Traditional Herbal Medicine Research Methods: Identification, Analysis, Bioassay, and Pharmaceutical and Clinical Sciences","article-title":"Safety pharmacology and toxicity study of herbal medicines","author":"Yang","year":"2011"},{"key":"10.1016\/j.fct.2016.11.001_bib161","series-title":"Traditional Herbal Medicine Research Methods: Identification, Analysis, Bioassay, and Pharmaceutical and Clinical Sciences","article-title":"Clinical study of traditional herbal medicine","author":"Yuen","year":"2011"},{"key":"10.1016\/j.fct.2016.11.001_bib162","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1021\/np9800102","article-title":"Recent natural products based drug development: a pharmaceutical industry perspective","volume":"61","author":"Yuie-Zhong","year":"1998","journal-title":"J.\u00a0Nat. Prod."}],"container-title":["Food and Chemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691516304021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691516304021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T21:37:43Z","timestamp":1759527463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278691516304021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":164,"alternative-id":["S0278691516304021"],"URL":"https:\/\/doi.org\/10.1016\/j.fct.2016.11.001","relation":{},"ISSN":["0278-6915"],"issn-type":[{"value":"0278-6915","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An overview of herb and dietary supplement efficacy, safety and government regulations in the United States with suggested improvements. Part 1 of 5 series","name":"articletitle","label":"Article Title"},{"value":"Food and Chemical Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fct.2016.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}